ABCELLERA BIOLOGICS (8QQ) — Free Cash Flow Generation Index
ABCELLERA BIOLOGICS (8QQ) has a Free Cash Flow Generation Index of 0.74x as of December 2022. Free cash flow of €204.70 Million represents 1% of operating cash flow (€277.36 Million). Read ABCELLERA BIOLOGICS total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ABCELLERA BIOLOGICS Free Cash Flow Generation Index (2021–2022)
Historical FCF Generation Index trend for ABCELLERA BIOLOGICS across 2 annual periods. Explore ABCELLERA BIOLOGICS (8QQ) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year Free Cash Flow Generation Index for ABCELLERA BIOLOGICS. For the full company profile including market capitalisation, see 8QQ market cap overview.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.74x | €204.70 Million | €277.36 Million | €72.66 Million | ▼ -3.0% |
| 2021 | 0.76x | €186.13 Million | €244.58 Million | €58.45 Million | — |